Declaration of Voting Results & Voting Rights Announcements • Jun 26, 2013
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 8547H
Silence Therapeutics PLC
26 June 2013
Silence Therapeutics plc ("Silence" or the "Company")
BOARD CHANGE
26 June 2013
Resignation of director
David Mack, non-executive director, is stepping down from the board of the Company ahead of today's annual general meeting. Based in San Francisco, he has been a director of the Company since the acquisition in 2010 of Intradigm Corporation. Alta Partners, where he is a director, disposed of its holding in Silence in November 2012. The board would like to express their thanks and appreciation to David for his work on the board of the Company, and wish him every success in his future endeavours.
For further information please contact:
Silence Therapeutics
Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3000
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPGUAUQUPWGRA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.